Fintel on MSN

Werewolf Therapeutics (HOWL) price target decreased by 10.86% to 5.30

The average one-year price target for Werewolf Therapeutics (NasdaqGS:HOWL) has been revised to $5.30 / share. This is a ...
Yahoo Finance

Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know

Werewolf Therapeutics, Inc. (HOWL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...
Yahoo Finance

Werewolf Therapeutics (HOWL) Eyes 2026 Catalysts Following FDA Guidance and Encouraging INDUKINE Results

On December 18, 2025, Werewolf Therapeutics, Inc. (NASDAQ:HOWL) shared a comprehensive pipeline update in which it highlighted clinical progress and 2026 priorities for its INDUKINE programs and ...
Nasdaq

B of A Securities Maintains Werewolf Therapeutics (HOWL) Buy Recommendation

Fintel reports that on May 12, 2023, B of A Securities maintained coverage of Werewolf Therapeutics (NASDAQ:HOWL) with a Buy recommendation. As of May 11, 2023, the average one-year price target for ...